BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37417600)

  • 1. Spontaneous resolution of cryptogenic organizing pneumonia: Observational study.
    Shimoda M; Tanaka Y; Morimoto K; Yoshimori K; Ohta K
    Medicine (Baltimore); 2023 Jul; 102(27):e34277. PubMed ID: 37417600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical features and prognosis in patients with cryptogenic and secondary organizing pneumonia.
    Choi KJ; Yoo EH; Kim KC; Kim EJ
    BMC Pulm Med; 2021 Oct; 21(1):336. PubMed ID: 34715829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal effective dose of maintenance steroid therapy for relapse of cryptogenic organizing pneumonia.
    Atsumi K; Hisakane K; Mikami E; Suzuki T; Matsuki S; Seike M; Hirose T
    Respir Med; 2023 Nov; 218():107390. PubMed ID: 37598895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution of an insidious and migratory Mycobacterium tuberculosis-associated secondary organizing pneumonia: a case report and literature review.
    Huang LL; Wang C; Liu Y; Gu XY; Wang WX; Chen W; Hu CM
    BMC Infect Dis; 2023 Jun; 23(1):372. PubMed ID: 37264312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for relapse of cryptogenic organizing pneumonia.
    Saito Z; Kaneko Y; Hasegawa T; Yoshida M; Odashima K; Horikiri T; Kinoshita A; Saitoh K; Kuwano K
    BMC Pulm Med; 2019 Jan; 19(1):10. PubMed ID: 30626371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic bronchiolitis obliterans organizing pneumonia/cryptogenic organizing pneumonia with unfavorable outcome: pathologic predictors.
    Yousem SA; Lohr RH; Colby TV
    Mod Pathol; 1997 Sep; 10(9):864-71. PubMed ID: 9310948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term retrospective study of patients with biopsy-proven cryptogenic organizing pneumonia.
    Zhou Y; Wang L; Huang M; Ding J; Jiang H; Zhou K; Meng F; Xiao Y; Cai H; Dai J
    Chron Respir Dis; 2019; 16():1479973119853829. PubMed ID: 31159568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of procalcitonin for differentiating cryptogenic organising pneumonia from community-acquired pneumonia.
    Ito A; Ishida T; Tachibana H; Arita M; Yamazaki A; Washio Y
    Clin Chem Lab Med; 2019 Sep; 57(10):1632-1637. PubMed ID: 31120857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Rituximab Therapy in Steroid-Resistant, Cryptogenic Organizing Pneumonia: A Case Series.
    Shitenberg D; Fruchter O; Fridel L; Kramer MR
    Respiration; 2015; 90(2):155-9. PubMed ID: 26045243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the clinical characteristics of 176 patients with pathologically confirmed cryptogenic organizing pneumonia.
    Zhang Y; Li N; Li Q; Zhou Y; Zhang F; Chen T; Shen L; Su Y; Hu Y; Li H
    Ann Transl Med; 2020 Jun; 8(12):763. PubMed ID: 32647688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between cryptogenic organizing pneumonia and connective tissue disease-related organizing pneumonia.
    Yoo JW; Song JW; Jang SJ; Lee CK; Kim MY; Lee HK; Jegal Y; Kim DS
    Rheumatology (Oxford); 2011 May; 50(5):932-8. PubMed ID: 21169342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chest CT imaging features for prediction of treatment response in cryptogenic and connective tissue disease-related organizing pneumonia.
    Cho YH; Chae EJ; Song JW; Do KH; Jang SJ
    Eur Radiol; 2020 May; 30(5):2722-2730. PubMed ID: 32040727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic organizing pneumonia: a relapsing disease. 19 years of experience in a hospital setting.
    Barroso E; Hernandez L; Gil J; Garcia R; Aranda I; Romero S
    Respiration; 2007; 74(6):624-31. PubMed ID: 17536184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchiolitis obliterans-organizing pneumonia: an Italian experience.
    Cazzato S; Zompatori M; Baruzzi G; Schiattone ML; Burzi M; Rossi A; Ratta L; Terzuolo G; Falcone F; Poletti V
    Respir Med; 2000 Jul; 94(7):702-8. PubMed ID: 10926343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of relapsed connective tissue disease-associated organizing pneumonia.
    Otsuka J; Yoshizawa S; Kudo K; Osoreda H; Ishimatsu A; Taguchi K; Moriwaki A; Wakamatsu K; Iwanaga T; Yoshida M
    Respir Med; 2023; 219():107419. PubMed ID: 37804996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic features associated with relapse in cryptogenic organizing pneumonia.
    Nishino M; Mathai SK; Schoenfeld D; Digumarthy SR; Kradin RL
    Hum Pathol; 2014 Feb; 45(2):342-51. PubMed ID: 24342432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial chest CT in cryptogenic organizing pneumonia: Evolutional changes and prognostic determinants.
    Chung MP; Nam BD; Lee KS; Han J; Park JS; Hwang JH; Cha MJ; Kim TJ
    Respirology; 2018 Mar; 23(3):325-330. PubMed ID: 28960643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptogenic organizing pneumonia: clinical profile in a series of 34 admitted patients in a hospital in India.
    Sen T; Udwadia ZF
    J Assoc Physicians India; 2008 Apr; 56():229-32. PubMed ID: 18702383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis.
    Drakopanagiotakis F; Paschalaki K; Abu-Hijleh M; Aswad B; Karagianidis N; Kastanakis E; Braman SS; Polychronopoulos V
    Chest; 2011 Apr; 139(4):893-900. PubMed ID: 20724743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Steroid Treatment for SARS-CoV-2 Pneumonia With Cryptogenic Organizing Pneumonia-Like Reaction: A Case Report.
    Kim T; Son E; Jeon D; Lee SJ; Lim S; Cho WH
    Disaster Med Public Health Prep; 2022 Apr; 16(2):491-494. PubMed ID: 33100248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.